Top Health Care Stocks:
Health care majors were retreating pre-market Tuesday.
Early movers include:
(+) Cidara Therapeutics (CDTX), which was surging by over 64% after the company said it has entered into a strategic tie-up worth up to $568 million with Mundipharma to develop and commercialize rezafungin to treat and prevent invasive fungal infections.
(+) Endo International (ENDP) was up more than 3% as its Par Pharmaceutical unit launched sales of an authorized generic version of Merck's (MRK) Noxafil delayed-release tablets, a treatment for fungal infections. Merck was slightly lower in recent trading.
(-) Aridis Pharmaceuticals (ARDS) was declining by more than 27% after saying it will no longer continue its development program for the drug AR-105 as a treatment for ventilator-associated pneumonia caused by pseudomonas aeruginosa after a phase 2 study failed to meet its primary endpoint.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.